Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Plasma cell 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 10Motor Activity 8Lymphoma 3Leukemia 2Hematologic Neoplasms 2Thyroid Neoplasms 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteolysis 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Kidney Neoplasms 1Hodgkin Disease 1Hematologic Diseases 1Fatigue 1Endometrial Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Diseases 1

Interventions

Trastuzumab 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1selinexor 1sapanisertib 1relatlimab 1pertuzumab 1pemigatinib 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1defactinib 1dabrafenib 1copanlisib 1capivasertib 1binimetinib 1adavosertib 1X-Rays 1Sunitinib 1Specimen Handling 1PF-05280014 1Ontruzant 1Ogivri 1Nuclear Medicine Department, Hospital 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Exercise × Plasma cell × Clear all
NCT04000880 2025-06-12

AMPLIFY

University of Alabama at Birmingham

Phase NA Active not recruiting
603 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡